Expression of Biliverdin Reductase A in peripheral blood leukocytes is associated with treatment response in HCV-infected patients.
Hepatitis C virus (HCV) infection is associated with systemic oxidative stress. Since the heme catabolic pathway plays an important role in antioxidant protection, we attempted to assess the gene expression of key enzymes of heme catabolism, heme oxygenase 1 (HMOX1), heme oxygenase 2 (HMOX2), and bi...
Main Authors: | Iva Subhanova, Lucie Muchova, Martin Lenicek, Hendrik J Vreman, Ondrej Luksan, Kristyna Kubickova, Miluse Kreidlova, Tomas Zima, Libor Vitek, Petr Urbanek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3594226?pdf=render |
Similar Items
-
No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C(♦)(♦)This work was supported by a grant No. NR9412-3/2007 given by the Czech Ministry of Health.
by: Petr Urbánek, et al.
Published: (2011-10-01) -
Go Green: The Antiinflammatory Effects of Biliverdin Reductase
by: Barbara eWegiel, et al.
Published: (2012-03-01) -
Biliverdin Reductase: a Target for Cancer Therapy?
by: Peter eGibbs, et al.
Published: (2015-06-01) -
Biliverdin reductase: more than a namesakeThe reductase, its peptide fragments and biliverdin regulate activity of the three classes of protein kinase C.
by: Peter E.M. Gibbs, et al.
Published: (2012-03-01) -
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
by: Remco van Dijk, et al.
Published: (2017-05-01)